Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Report
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis
Sarah Lowa Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA
https://orcid.org/0000-0001-7587-6435
https://orcid.org/0000-0001-7587-6435, , , , Birgit Fogalb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0002-1682-7729
https://orcid.org/0000-0002-1682-7729, , , , , Valentina Bergerb Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0001-9597-3638
https://orcid.org/0000-0001-9597-3638, , , , Jennifer Ahlbergd Biotherapeutics Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0002-2892-4163
https://orcid.org/0000-0002-2892-4163, , , , , , Sanjaya Singha Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USAhttps://orcid.org/0000-0002-9119-7966
https://orcid.org/0000-0002-9119-7966 & Rachel Kroe-Barretta Biotherapeutics Molecule Discovery, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USACorrespondence[email protected]
https://orcid.org/0000-0003-1413-1223
https://orcid.org/0000-0003-1413-1223 show all